McKesson (MCK) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.

The company reported a big net income increase for the first quarter, but its revenue fell on sluggishness in its loan facilitation business

CNA Financial is a reliable 'proxy bond' investment, offering predictable returns and a strong, gradually increasing dividend for income-focused investors. Recent Q1 2025 results showed margin deterioration due to higher loss ratios and claim inflation, but no alarming trends for long-term holders. The 8% dividend yield, boosted by regular and special dividends, is the main attraction, though the special dividend can be cut in tough years.

I reiterate my buy rating for GLBE, as recent results and SHOP partnership updates enhance scalability and long-term growth potential. GLBE delivered strong Q1'25 results, with GMV and revenue both growing over 30% year-over-year and profitability improving significantly. The Shopify partnership extension, despite short-term topline optics, increases platform integration and should drive higher adoption and transaction volumes.

Von Duprin's first offering engineered to protect internal components on outdoor applications CARMEL, Ind. , May 28, 2025 /PRNewswire/ -- Allegion US , a leading provider of security solutions, technology and services, has introduced the Outdoor Defense (OUT) option for 98/99 exit devices, the first Von Duprin product designed to protect device functionality in outdoor conditions, providing the reliability, quality and function expected from Von Duprin.

NEW YORK CITY, NY / ACCESS Newswire / May 28, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of UroGen Pharma Ltd. ("UroGen" or "the Company") (NASDAQ:URGN).

NEW YORK CITY, NY / ACCESS Newswire / May 28, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Meta Platforms, Inc. ("Meta" or "the Company") (NASDAQ:META). Investors who purchased Meta securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/META.

NEW YORK CITY, NY / ACCESS Newswire / May 28, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of EchoStar Corporation ("EchoStar" or "the Company") (NASDAQ:SATS). Investors who purchased EchoStar securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/SATS.

NEW YORK CITY, NY / ACCESS Newswire / May 28, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Cleveland-Cliffs Inc. ("Cleveland-Cliffs" or "the Company") (NYSE:CLF). Investors who purchased Cleveland-Cliffs securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/CLF.

NEW YORK CITY, NY / ACCESS Newswire / May 28, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Take-Two Interactive Software, Inc. ("Take-Two" or "the Company") (NASDAQ:TTWO). Investors who purchased Take-Two securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/TTWO.

NEW YORK, NY / ACCESS Newswire / May 28, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Coinbase Global, Inc. ("Coinbase" or "the Company") (NASDAQ:COIN). Investors who purchased Coinbase securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/COIN.

NEW YORK CITY, NY / ACCESS Newswire / May 28, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Travere Therapeutics, Inc. ("Travere" or "the Company") (NASDAQ:TVTX). Investors who purchased Travere securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/TVTX.

NEW YORK, NY / ACCESS Newswire / May 28, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Schrödinger, Inc. ("Schrödinger" or "the Company") (NASDAQ:SDGR). Investors who purchased Schrödinger securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/SDGR.

NEW YORK CITY, NY / ACCESS Newswire / May 28, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of GoHealth, Inc. ("GoHealth" or "the Company") (NASDAQ:GOCO). Investors who purchased GoHealth securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/GOCO.

NEW YORK CITY, NY / ACCESS Newswire / May 28, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Capricor Therapeutics, Inc. ("Capricor" or "the Company") (NASDAQ:CAPR). Investors who purchased Capricor securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/CAPR.

NEW YORK CITY, NY / ACCESS Newswire / May 28, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Integra LifeSciences Holdings Corporation ("Integra" or "the Company") (NASDAQ:IART). Investors who purchased Integra securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/IART.

NEW YORK CITY, NY / ACCESS Newswire / May 28, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Apple Inc. ("Apple" or "the Company") (NASDAQ:AAPL). Investors who purchased Apple securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/AAPL.

NEW YORK CITY, NY / ACCESS Newswire / May 28, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Senti Biosciences, Inc. ("Senti" or "the Company") (NASDAQ:SNTI). Investors who purchased Senti securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/SNTI.

LEHIGH VALLEY, Pa. , May 28, 2025 /PRNewswire/ -- Air Products' (NYSE:APD) CEO Eduardo Menezes will speak at Deutsche Bank's 16th Annual Global Industrials & Materials Conference on Wednesday, June 4, 2025 at 8:00 a.m.

NEW YORK, NY / ACCESS Newswire / May 28, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Fulgent Genetics, Inc. ("Fulgent" or "the Company") (NASDAQ:FLGT). Investors who purchased Fulgent securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/FLGT.